{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:35:01Z","timestamp":1779291301850,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.antiviral.2012.02.005","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T17:45:42Z","timestamp":1329587142000},"page":"44-53","source":"Crossref","is-referenced-by-count":50,"title":["Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox \u2013 An animal model of smallpox"],"prefix":"10.1016","volume":"94","author":[{"given":"Scott","family":"Parker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanhai G.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hollyce","family":"Hartzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Hembrador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall","family":"Lanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Painter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley","family":"Painter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Sagartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Schriewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mark Buller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.02.005_b0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1874357901004010088","article-title":"Detection of HIV-1 in saliva: implications for case-identification, clinical monitoring and surveillance for drug resistance","volume":"4","author":"Balamane","year":"2010","journal-title":"Open Virol. J."},{"key":"10.1016\/j.antiviral.2012.02.005_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdermsci.2008.08.012","article-title":"The hairless mouse in skin research","volume":"53","author":"Benavides","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.antiviral.2012.02.005_b0015","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/0022034511413283","article-title":"Salivary detection of H1N1 virus: a clinical feasibility investigation","volume":"90","author":"Bilder","year":"2011","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.antiviral.2012.02.005_b0020","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","article-title":"Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns","volume":"364","author":"Boppana","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2012.02.005_b0025","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/JCM.18.5.1220-1225.1983","article-title":"Evaluation of an enzyme-linked immunosorbent assay for the detection of ectromelia (mousepox) antibody","volume":"18","author":"Buller","year":"1983","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0030","series-title":"The Mouse in Biomedical Research","author":"Buller","year":"2007"},{"key":"10.1016\/j.antiviral.2012.02.005_b0290","unstructured":"CFR, 2011. Code of Federal Regulations Title 21, Vol. 5, Chapter I, Subchapter D, Part 314."},{"key":"10.1016\/j.antiviral.2012.02.005_b0040","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0300985810378649","article-title":"Animal models of orthopoxvirus infection","volume":"47","author":"Chapman","year":"2010","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2010.10.021","article-title":"Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: Pathogenesis, prophylaxis, and antiviral therapy","volume":"409","author":"Chen","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.02.005_b0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0042-6822(92)90445-U","article-title":"Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene","volume":"187","author":"Chen","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.02.005_b0055","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","article-title":"Ectromelia virus: the causative agent of mousepox","volume":"86","author":"Esteban","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0060","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.64.6.3108-3111.1990","article-title":"Transient dominant selection of recombinant vaccinia viruses","volume":"64","author":"Falkner","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0065","unstructured":"FDA, 2009. Guidance for industry. Animal models - essential elements to address efficacy under the animal rule, in: FDA (Ed.)."},{"key":"10.1016\/j.antiviral.2012.02.005_b0070","first-page":"553","article-title":"Mousepox (infectious ectromelia): past, present, and future","volume":"31","author":"Fenner","year":"1981","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.antiviral.2012.02.005_b0075","series-title":"Smallpox and Its Eradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.antiviral.2012.02.005_b0080","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2009.06.105","article-title":"Evaluation of the efficacy of modified vaccinia Ankara (MVA)\/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model","volume":"27","author":"Garza","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2012.02.005_b0085","first-page":"167","article-title":"Synthesis and antiviral evaluation of broad spectrum, orally active analogs of cidofovir and other acyclic nucleoside phosphonates","volume":"5","author":"Hostetler","year":"2007"},{"key":"10.1016\/j.antiviral.2012.02.005_b0090","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0095","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1128\/JVI.01931-10","article-title":"Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route","volume":"85","author":"Johnson","year":"2011","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2012.02.005_b0100","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1093\/nar\/gkn1055","article-title":"Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples","volume":"37","author":"Kermekchiev","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2012.02.005_b0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2004.02.031","article-title":"Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis","volume":"324","author":"Kerr","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.02.005_b0110","first-page":"466","article-title":"Experimental respiratory infection with poxviruses. II. Pathological studies","volume":"47","author":"Lancaster","year":"1966","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0115","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1099\/vir.0.81331-0","article-title":"Complete coding sequences of the rabbitpox virus genome","volume":"86","author":"Li","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jviromet.2006.12.005","article-title":"Orthopoxvirus pan-genomic DNA assay","volume":"141","author":"Li","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2012.02.005_b0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4269\/ajtmh.2009.80.503","article-title":"Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo","volume":"80","author":"MacNeil","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2012.02.005_b0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1590\/S0074-02762011000300020","article-title":"Detection of human herpesvirus 7 infection in young children presenting with exanthema subitum","volume":"106","author":"Magalhaes Ide","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.antiviral.2012.02.005_b0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1258\/0023677041958981","article-title":"Non-invasive method for sampling and extraction of mouse DNA for PCR","volume":"38","author":"Meldgaard","year":"2004","journal-title":"Lab. Anim."},{"key":"10.1016\/j.antiviral.2012.02.005_b0140","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/JCM.40.8.2919-2921.2002","article-title":"Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001","volume":"40","author":"Meyer","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antiviral. Res."},{"issue":"9","key":"10.1016\/j.antiviral.2012.02.005_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012880","article-title":"Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus","volume":"5","author":"Nalca","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2012.02.005_b0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.tibtech.2011.01.007","article-title":"Point-of-care nucleic acid testing for infectious diseases","volume":"29","author":"Niemz","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0160","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1128\/JCM.42.5.1940-1946.2004","article-title":"Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus","volume":"42","author":"Olson","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tibtech.2004.06.008","article-title":"Design and development of oral drugs for the prophylaxis and treatment of smallpox infection","volume":"22","author":"Painter","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0170","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2217\/17460794.3.6.595","article-title":"Therapeutic and prophylactic drugs to treat orthopoxvirus infections","volume":"3","author":"Parker","year":"2008","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"Parker","year":"2007","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/135965350801300703","article-title":"Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001","volume":"13","author":"Parker","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2012.02.005_b0185","series-title":"Encyclopedia of Virology","first-page":"639","article-title":"Smallpox and monkeypox vruses","author":"Parker","year":"2008"},{"key":"10.1016\/j.antiviral.2012.02.005_b0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2008.11.015","article-title":"Mousepox in the C57BL\/6 strain provides an improved model for evaluating anti-poxvirus therapies","volume":"385","author":"Parker","year":"2009","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.antiviral.2012.02.005_b0195","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/v2091918","article-title":"Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics","volume":"2","author":"Parker","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2012.02.005_b0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","article-title":"Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model","volume":"77","author":"Parker","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.02.005_b0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-422X-7-22","article-title":"Detection of dengue virus in saliva and urine by real time RT-PCR","volume":"7","author":"Poloni","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2012.02.005_b0210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.02.005_b0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2004.02.003","article-title":"Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir","volume":"63","author":"Quenelle","year":"2004","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2012.02.005_b0220","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1128\/AAC.00762-07","article-title":"Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.02.005_b0225","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2012.02.005_b0230","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3201\/eid1306.061540","article-title":"Endemic human monkeypox, Democratic Republic of Congo, 2001\u20132004","volume":"13","author":"Rimoin","year":"2007","journal-title":"Emerg. Infect. Dis."},{"issue":"37","key":"10.1016\/j.antiviral.2012.02.005_b0235","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.02.005_b0240","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/v2092096","article-title":"Use of the aerosol rabbitpox virus model for evaluation of anti-poxvirus agents","volume":"2","author":"Roy","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2012.02.005_b0245","first-page":"1800","article-title":"Duration of virus excretion in the throat of asymptomatic household contacts of smallpox patients","volume":"62","author":"Sarkar","year":"1974","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.antiviral.2012.02.005_b0250","first-page":"517","article-title":"Virus excretion in smallpox 1","author":"Sarkar","year":"1973","journal-title":"Bull. World Health Organization"},{"key":"10.1016\/j.antiviral.2012.02.005_b0255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.virol.2008.09.025","article-title":"Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus","volume":"383","author":"Schultz","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.02.005_b0260","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.02173-10","article-title":"Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus","volume":"85","author":"Smith","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0265","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000233027","article-title":"Immune responses in nonhaired mice","volume":"67","author":"Smith","year":"1982","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0270","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JVI.02012-09","article-title":"A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus","volume":"84","author":"Stabenow","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0275","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0280","first-page":"453","article-title":"Experimental respiratory infection with poxviruses. I. Clinical virological and epidemiological studies","volume":"47","author":"Westwood","year":"1966","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.antiviral.2012.02.005_b0285","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212000381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212000381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T21:12:12Z","timestamp":1686777132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212000381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0166354212000381"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.02.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}